CMS Finalizes Limited Medicare Coverage of Alzheimer’s Treatment
- April 08, 2022
Medicare will cover a controversial treatment for Alzheimer’s disease only for patients who are enrolled in randomized controlled clinical trials under a final National Coverage Determination (NCD) issued by the Centers for Medicare & Medicaid Services (CMS) on April 7.
ARTICLE TAGS
You must be logged in to access this content.